Christos Sachpekidis

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

Hoda Anwar, Christos Sachpekidis, Julia K. Winkler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 190 citations

Oncologic Imaging, Suv Changes, Melanoma +6

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI

Martin T. Freitag, Jan Philipp Radtke, Ali Afshar‐Oromieh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 161 citations

Positron Emission Tomography, Urology, Surgical Oncology +11

Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study

Christos Sachpekidis, Lionel Larribère, Leyun Pan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 151 citations

Oncologic Imaging, Melanoma, Metastatic Melanoma +8

Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape

Efstathios–Iason Vlachavas, Eleftherios Pilalis, Olga Papadodima et al. · Computational and Structural Biotechnology Journal · 2019 · 135 citations · Full text

68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer

Christos Sachpekidis, Klaus Kopka, Matthias Eder et al. · Clinical Nuclear Medicine · 2016 · 116 citations